Leerink Partnrs Reduces Earnings Estimates for agilon health

agilon health, inc. (NYSE:AGL) – Equities research analysts at Leerink Partnrs reduced their FY2024 earnings per share (EPS) estimates for agilon health in a report issued on Monday, November 11th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn ($0.65) per share for the year, down from their previous forecast of ($0.35). The consensus estimate for agilon health’s current full-year earnings is ($0.35) per share. Leerink Partnrs also issued estimates for agilon health’s Q4 2024 earnings at ($0.27) EPS, Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.19) EPS, Q4 2025 earnings at ($0.20) EPS, FY2025 earnings at ($0.39) EPS, FY2026 earnings at ($0.26) EPS, FY2027 earnings at ($0.18) EPS and FY2028 earnings at ($0.07) EPS.

Several other analysts also recently issued reports on the company. TD Cowen lowered their price target on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday. Evercore ISI lowered their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Stifel Nicolaus reduced their price target on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday. Benchmark reaffirmed a “buy” rating and issued a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. Finally, Barclays dropped their price objective on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $6.38.

agilon health Price Performance

agilon health stock opened at $1.72 on Thursday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $708.67 million, a P/E ratio of -2.01 and a beta of 0.60. The firm has a fifty day moving average of $3.14 and a 200-day moving average of $4.90. agilon health has a 52-week low of $1.70 and a 52-week high of $13.76.

agilon health (NYSE:AGL) last posted its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period last year, the company posted ($0.06) EPS.

Hedge Funds Weigh In On agilon health

A number of hedge funds have recently added to or reduced their stakes in AGL. Vanguard Group Inc. lifted its position in shares of agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after buying an additional 371,537 shares during the last quarter. AQR Capital Management LLC raised its stake in agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC lifted its holdings in agilon health by 65.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after acquiring an additional 316,856 shares during the last quarter. Capital International Investors boosted its stake in agilon health by 84.7% in the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after acquiring an additional 9,263,296 shares during the period. Finally, Simplicity Wealth LLC grew its holdings in shares of agilon health by 145.1% during the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock valued at $171,000 after purchasing an additional 15,515 shares during the last quarter.

Insider Transactions at agilon health

In other news, CEO Steven Sell purchased 20,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were acquired at an average cost of $3.36 per share, with a total value of $67,200.00. Following the transaction, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. The trade was a 42.03 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 3.20% of the company’s stock.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.